Atorvastatin mediates increases in intralesional BAX and BAK expression in human end-stage abdominal aortic aneurysms

Canadian Journal of Physiology and Pharmacology

Volumn 87, Issue 11, 2009, Pages 915-922

  Schweitzer, Morris ^a   Mitmaker, Benjamin ^a   Obrand, Daniel ^a   Sheiner, Nathan ^a   Abraham, Cherrie ^a   Dostanic, Stevan ^b   Chalifour, Lorraine E ^a,b,c  

^a MCGILL UNIVERSITY   (Canada)

^b MCGILL UNIVERSITY   (Canada)

^c MCGILL UNIVERSITY   (Canada)

Author keywords

Abdominal aortic aneurysm; Apoptosis; Atorvastatin; Bak; Bax; Bcl 2

Indexed keywords

ATORVASTATIN; BINDING PROTEIN; CASPASE 3; CLUSTERIN; COMPLEMENTARY DNA; CYTOCHROME C; GLUCOSE REGULATED PROTEIN 78; PROTEIN BAK; PROTEIN BAX; PROTEIN BNIP1; PROTEIN P20; TUBULIN; UNCLASSIFIED DRUG;

ABDOMINAL AORTA ANEURYSM; AGED; APOPTOSIS; ARTICLE; BAX GENE; BCL 2 GENE; CELL FUNCTION; CLINICAL ARTICLE; CONTROLLED STUDY; DNA SEQUENCE; ENDOPLASMIC RETICULUM; ENZYME RELEASE; FEMALE; GENE; HOMEOSTASIS; HUMAN; HUMAN TISSUE; IMMUNOBLOTTING; MALE; NUCLEOTIDE SEQUENCE; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN ISOLATION;

AGED; AGED, 80 AND OVER; AORTA, ABDOMINAL; AORTIC ANEURYSM, ABDOMINAL; APOPTOSIS REGULATORY PROTEINS; BCL-2 HOMOLOGOUS ANTAGONIST-KILLER PROTEIN; BCL-2-ASSOCIATED X PROTEIN; CASPASE 3; DISEASE PROGRESSION; FEMALE; GENE EXPRESSION REGULATION; HEPTANOIC ACIDS; HUMANS; HYDROXYMETHYLGLUTARYL-COA REDUCTASE INHIBITORS; MALE; MIDDLE AGED; POLYMORPHISM, SINGLE NUCLEOTIDE; PYRROLES; REVERSE TRANSCRIPTASE POLYMERASE CHAIN REACTION; RNA, MESSENGER;

EID: 74849109978     PISSN: 00084212     EISSN: None     Source Type: Journal    
DOI: 10.1139/Y09-085     Document Type: Article

References (53)

1. Annambhotla, S., Bourgeois, S., Wang, X., Lin, P.H., Yao, Q., and Chen, C. 2008. Recent advances in molecular mechanisms of abdominal aortic aneurysm formation. World J. Surg. 32(6): 976-986. doi:10.1007/s00268-007-9456-x. PMID:18259804.
2. Blanco-Colio, L.M., Villa, A., Ortego, M., Hernández-Presa, M.A., Pascual, A., Plaza, J.J., and Egido, J. 2002. 3-Hydroxy-3-methyl-glutaryl coenzyme A reductase inhibitors, atorvastatin and simvastatin, induce apoptosis of vascular smooth muscle cells by downregulation of Bcl-2 expression and Rho A prenylation. Atherosclerosis, 161(1): 17-26. doi:10.1016/S0021-9150(01) 00613-X. PMID:11882313.
3. Bossy-Wetzel, E., and Green, D.R. 2000. Assays for cytochrome c release from mitochondria during apoptosis. Methods Enzymol. 322: 235-242. doi:10.1016/S0076-6879(00)22024-7. PMID:10914021.
4. Bown, M.J., Sutton, A.J., Bell, P.R., and Sayers, R.D. 2002. A meta-analysis of 50 years of ruptured abdominal aortic aneurysm repair. Br. J. Surg. 89(6): 714-730. doi:10.1046/j.1365-2168.2002.02122.x. PMID:12027981.
5. Chandra, D., Choy, G., Daniel, P.T., and Tang, D.G. 2005. Bax-dependent regulation of Bak by voltage-dependent anion channel 2. J. Biol. Chem. 280(19): 19051-19061. doi:10.1074/jbc.M501391200. PMID:15757910.
6. Chipuk, J.E., and Green, D.R. 2008. How do BCL-2 proteins induce mitochondrial outer membrane permeabilization? Trends Cell Biol. 18(4): 157-164. doi:10.1016/j.tcb.2008.01.007. PMID:18314333.
7. Danial, N.N., and Korsmeyer, S.J. 2004. Cell death: critical control points. Cell, 116(2): 205-219. doi:10.1016/S0092-8674(04)00046-7. PMID:14744432.
8. Darling, R.C. 1970. Ruptured arteriosclerotic abdominal aortic aneurysms. A pathologic and clinical study. Am. J. Surg. 119(4): 397-401. doi:10.1016/0002-9610(70)90140-6. PMID:4908753.
9. Davignon, J. 2004. Beneficial cardiovascular pleiotropic effects of statins. Circulation, 109(23 Suppl 1): III39-III43. doi:10.1161/01.CIR. 0000131517.20177.5a.
10. Ernst, C.B. 1993. Abdominal aortic aneurysm. N. Engl. J. Med. 328(16): 1167-1172. doi:10.1056/NEJM199304223281607. PMID:8455684.
11. Golledge, J., Abrokwah, J., Shenoy, N., and Armour, R.H. 1999. Morphology of ruptured abdominal aortic aneurysms. Eur. J. Endovasc. Surg. 18(2): 96-104. doi:10.1053/ejvs.1998.0786.
12. Golledge, J., Muller, J., Daugherty, A., and Norman, P. 2006. Abdominal aortic aneurysm: pathogenesis and implications for management. Arterioscler. Thromb. Vase. Biol. 26(12): 2605-2613. doi:10.1161/01.ATV.0000245819. 32762.cb. PMID:16973970.
13. Guessous, I., Periard, D., Lorenzetti, D., Cornuz, J., Ghali, W.A., and Timmer, A. 2008. The efficacy of pharmacotherapy for decreasing the expansion rate of abdominal aortic aneurysms: a systematic review and meta-analysis. PLoS One, 3(3): e1895. doi:10.1371/journal.pone.0001895. PMID:18365027.
14. Guo, F., Li, Z., Song, L., Han, T., Feng, Q., Guo, Y., et al. 2007. Increased apoptosis and cysteinyl aspartate specific protease-3 gene expression in human intracranial aneurysm. J. Clin. Neurosci. 14(6): 550-555. doi:10.1016/j.jocn.2005.11.018. PMID:17430778.
15. Henderson, E.L., Geng, Y.-J., Sukhova, G.K., Whittemore, A.D., Knox, J., and Libby, P. 1999. Death of smooth muscle cells and expression of mediators of apoptosis by T lymphocytes in human abdominal aortic aneurysms. Circulation, 99(1): 96-104. PMID:9884385.
16. Hetz, C., and Glimcher, L. 2008. The daily job of night killers: alternative roles of the BCL-2 family in organelle physiology. Trends Cell Biol. 18(1): 38-44. doi:10.1016/j.tcb.2007.10.003.
17. Hetz, C., Bernasconi, P., Fisher, J., Lee, A.H., Bassik, M.C., Antonsson, B., et al. 2006. Proapoptotic BAX and BAK modulate the unfolded protein response by a direct interaction with IR-E1alpha. Science, 312(5773): 572-576. doi:10.1126/science.1123480. PMID:16645094.
18. Ii, M., and Losordo, D.W. 2007. Statins and the endothelium. Vascul. Pharmacol. 46(1): 1-9. doi:10.1016/j.vph.2006.06.012. PMID:16920035.
19. Kalyanasundaram, A., Elmore, J.R., Manazer, J.R., Golden, A., Franklin, D.P., Galt, S.W., et al. 2006. Simvastatin suppresses experimental aortic aneurysm expansion. J. Vasc. Surg. 43(1): 117-124. doi:10.1016/j.jvs. 2005.08.007. PMID:16414398.
20. Kertai, M.D., Boersma, E., Westerhout, C.M., van Domburg, R., Klein, J., Bax, J.J., et al. 2004. Association between long-term statin use and mortality after successful abdominal aortic aneurysm surgery. Am. J. Med. 116(2): 96-103. doi:10.1016/j.amjmed.2003.08.029. PMID:14715323.
21. Kim, R., Emi, M., Tanabe, K., and Murakami, S. 2006. Role of the unfolded protein response in cell death. Apoptosis, 11(1): 5-13. doi:10.1007/s10495-005-3088-0. PMID:16374548.
22. Knapp, A.C., Huang, J., Starling, G., and Kiener, P.A. 2000. Inhibitors of HMG-CoA reductase sensitize human smooth muscle cells to Fas-ligand and cytokine-induced cell death. Atherosclerosis, 152(1): 217-227. doi:10.1016/S0021-9150(99)004621. PMID:10996358.
23. Lea, A.P., and McTavish, D. 1997. Atorvastatin: a review of its pharmacology and therapeutic potential in the management of hyperlipidaemias. Drugs, 53(5): 828-847. doi:10.2165/00003495-199753050-00011. PMID:9129869.
24. Lemasters, J.J., and Holmuhamedov, E. 2006. Voltage-dependent anion channel (VDAC) as mitochondrial governator[UNKNOWN ENTITY -]thinking outside the box. Biochim. Biophys. Acta, 1762(2): 181-190. PMID:16307870.
25. Leonarduzzi, G., Poli, G., Sottero, B., and Biasi, F. 2007. Activation of the mitochondrial pathway of apoptosis by oxysterols. Front. Biosci. 12(1): 791-799. doi:10.2741/2102. PMID:17127339.
26. Li, J., and Yuan, J. 2008. Caspases in apoptosis and beyond. Oncogene, 27(48): 6194-6206. doi:10.1038/onc.2008.297. PMID:18931687.
27. Liao, J.K. 2005. Effects of statins on 3-hydroxy-3-methylglutaryl coenzyme A reductase inhibition beyond low-density lipoprotein cholesterol. Am. J. Cardiol. 96(5): 24-33. doi:10.1016/j.amjcard. 2005.06.009.
28. Mateos-Cáceres, P.J., López-Farré, A.J., Morata, P.C., Ramos-Mozo, P., Macaya, C., Serrano, F.J., and Moñux, G. 2008. Pravastatin increases the expression of the tissue inhibitor of matrix metalloproteinase-1 and the oncogene Bax in human aortic abdominal ancurysms. Can. J. Physiol. Pharmacol. 86(7): 431-437. doi:10.1139/Y08-060. PMID:18641692.
29. McBride, H., Neuspiel, M., and Wadiak, S. 2006. Mitochondria: more than just a powerhouse. Curr. Biol. 16(14): R551-R560. doi:10.1016/j.cub.2006. 06.054.
30. Mück, A.O., Seeger, H., and Wallwiener, D. 2004. Class-specific pro-apoptotic effect of statins on human vascular endothelial cells. Z. Kardiol. 93(5): 398-402. doi:10.1007/s00392-004-0081-5. PMID:15160275.
31. Murphy, E., Imahashi, K., and Steenbergen, C. 2005. Bcl-2 regulation of mitochondrial energetics. Trends Cardiovasc. Med. 15(8): 283-290. doi:10.1016/j.tcm.2005.09.002. PMID:16297765.
32. Ni, M., and Lee, A.S. 2007. ER chaperones in mammalian development and human diseases. FEBS Lett. 581(19): 3641-3651. doi:10.1016/j.febslet. 2007.04.045. PMID:17481612.
33. Oakes, S.A., Lin, S.S., and Bassik, M.C. 2006. The control of en-doplasmic reticulum-initiated apoptosis by the BCL-2 family of proteins. Curr. Mol. Med. 6(1): 99-109. doi:10.2174/156652406775574587. PMID:16472117.
34. Outinen, P.A., Sood, S.K., Liaw, P.C., Sarge, K.D., Maeda, N., Hirsh, J., et al. 1998. Characterization of the stress-inducing effects of homocysteine. Biochem. J. 332(Pt 1): 213-221. PMID:9576870.
35. Rostovtseva, T.K., Tan, W., and Colombini, M. 2005. On the role of VDAC in apoptosis: fact and fiction. J. Bioenerg. Biomembr. 37(3): 129-142. doi:10.1007/s10863-005-6566-8. PMID:16167170.
36. Rowe, V.L., Stevens, S.L., Reddick, T.T., Freeman, M.B., Donnell, R., Carroll, R.C., and Goldman, M.H. 2000. Vascular smooth muscle cell apoptosis in aneurysmal, occlusive, and normal human aortas. J. Vasc. Surg. 31(3): 567-576. doi:10.1016/S0741-5214(00)90319-7. PMID:10709071.
37. Salvayre, R., Auge, N., Benoist, H., and Negre-Salvayre, A. 2002. Oxidized low-density lipoprotein-induced apoptosis. Biochim. Biophys. Acta, 1585(2-3): 213-221. PMID:12531556.
38. Sandford, R.M., Bown, M.J., London, N.J., and Sayers, R.D. 2007. The genetic basis of abdominal aortic aneurysms: a review. Eur. J. Vasc. Surg. 33(4): 381-390. doi:10.1016/j.ejvs.2006.10.025.
39. Sanson, M., Augé, N., Vindis, C., Muller, C., Bando, Y., Thiers, J.-C, et al. 2009. Oxidized low-density lipoproteins trigger endoplasmic reticulum stress in vascular cells: prevention by oxygen-regulated protein 150 expression. Circ. Res. 104(3): 328-336. doi:10.1161/CIRCRESAHA.108. 183749. PMID:9106412.
40. Satta, J., Mennander, A., and Soini, Y. 2002. Increased medial TUNEL-positive staining associated with apoptotic bodies is linked to smooth muscle cell diminution during evolution of abdominal aortic aneurysms. Ann. Vasc. Surg. 16(4): 462-466. doi:10.1007/s10016-001-0071-2. PMID:12132024.
41. Schouten, O., van Laanen, J.H.H., Boersma, E., Vidalovic, R., Feringa, H.H.H., Dunkeigrun, M., et al. 2006. Statins are associated with a reduced infrarenal abdominal aortic aneurysm growth. Eur. J. Endovasc. Surg. 32(1): 21-26. doi:10.1016/j.ejvs.2005.12.024.
42. Schwarz, M., Spath, L., Lux, C.A., Paprotka, K., Torzewski, M., Dersch, K., et al. 2008. Potential protective role of apoprotein J (clusterin) in atherogenesis: binding to enzymatically modified low-density lipoprotein reduces fatty acid-mediated cytotoxicity. Thromb. Haemost. 100(1): 110-118. PMID:18612545.
43. Sheridan, C., and Martin, S.J. 2008. Commitment in apoptosis: slightly dead but mostly alive. Trends Cell Biol. 18(8): 353-357. doi:10.1016/j.tcb.2008.06.002. PMID:18603426.
44. Stoneman, V.E., and Bennett, M.R. 2004. Role of apoptosis in atherosclerosis and its therapeutic implications. Clin. Sci. (Lond.), 107(4): 343-354. PMID:5230690.
45. Sukhija, R., Aronow, W.S., Sandhu, R., Kakar, P., and Babu, S. 2006. Mortality and size of abdominal aortic aneurysm at longterm follow-up of patients not treated surgically and treated with and without statins. Am. J. Cardiol. 97(2): 279-280. doi:10.1016/j.amjcard.2005.08.033. PMID:16442379.
46. Thompson, R.W., Geraghty, P.J., and Lee, J.K. 2002. Abdominal aortic aneurysms: basic mechanisms and clinical implications. Curr. Probl. Surg. 39(2): 110-230. doi:10.1067/msg.2002.121421. PMID:11884965.
47. Thompson, A.R., Drenos, F., Hafez, H., and Humphries, S.E. 2008. Candidate gene association studies in abdominal aortic aneurysm disease: a review and meta-analysis. Eur. J. Vasc. Endovasc. Surg. 35(1): 19-30. doi:10.1016/j.ejvs.2007.07.022. PMID:17920311.
48. Wang, X. 2001. The expanding role of mitochondria in apoptosis. Genes Dev. 15(22): 2922-2933. PMID:11711427.
49. Wasiak, S., Zunino, R., and McBride, H.M. 2007. Bax/Bak promote sumoylation of DRP1 and its stable association with mitochondria during apoptotic cell death. J. Cell Biol. 177(3): 439-450. doi:10.1083/jcb. 200610042. PMID:17470634.
50. Werstuck, G.H., Lentz, S.R., Dayal, S., Hossain, G.S., Sood, S.K., Shi, Y.Y., et al. 2001. Homocysteine-induced endoplasmic reticulum stress causes dysregulation of the cholesterol and triglyceride biosynthetic pathways. J. Clin. Invest. 107(10): 1263-1273. doi:10.1172/JCI11596. PMID:11375416.
51. Wiviott, S.D., and Cannon, C.P. 2006. The safety and efficacy of achieving very low LDL-cholesterol concentrations with high dose statin therapy. Curr. Opin. Lipidol. 17(6): 626-630. doi:10.1097/MOL.0b013e328010872d. PMID:17095906.
52. Zhang, J., Schmidt, J., Ryschich, E., Schumacher, H., and Allenberg, J.R. 2003. Increased apoptosis and decreased density of medial smooth muscle cells in human abdominal aortic aneurysms. Chin. Med. J. (Engl.), 116(10): 1549-1552. PMID:14570621.
53. Zhang, H., Kim, J.K., Edwards, C.A., Xu, Z., Taichman, R., and Wang, C.Y. 2005. Clusterin inhibits apoptosis by interacting with activated Bax. Nat. Cell Biol. 7(9): 909-915. doi:10.1038/ncb1291. PMID:16113678.